Skip to main content

The Impact of Fabry Disease on Reproductive Fitness

  • Research Report
  • Chapter
  • First Online:
JIMD Reports, Volume 37

Abstract

Fabry disease (FD) is a pan-ethnic, X-linked, progressive lysosomal storage disorder caused by pathogenic mutations in the GLA gene. Published case reports and abstracts suggest that decreased reproductive fitness may occur in males with FD. In order to understand the impact of FD on reproductive fitness and increase the accuracy of reproductive genetic counseling, this study examines a large, multi-centered population of individuals with FD to determine if males have reduced reproductive fitness. Study data were collected on 376 patients through two, gender-specific surveys distributed across the United States and Canada. The number of biological live-born children among individuals with FD was compared to statistics from the general population. Information was also collected on reduced sperm count, depression, pain, use of assisted reproductive technology, and reproductive choice. On average, females affected by FD had more biological live-born children (1.8) than males affected by FD (1.1). However, males affected by FD had an increased mean number of biological children (1.1) compared to the mean number of biological children fathered by men in the United States (0.9). Sixteen of the 134 males with FD reported oligospermia, which suggests that an infertility work up may be indicated for males having difficulty impregnating their partners. In our large multicenter sample, males and females with FD do not exhibit reduced reproductive fitness; on average they have more biological children than the general population in the United States. This information should assist clinicians in providing accurate reproductive genetic counseling and treatment for individuals with FD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Arends M, Hollak CE, Biegstraaten M (2015) Quality of life in patients with Fabry disease: a systematic review of the literature. Orphanet J Rare Dis 10:77

    Article  PubMed  PubMed Central  Google Scholar 

  • Beeson D, Golbus MS (1985) Decision making: whether or not to have prenatal diagnosis and abortion for X-linked conditions. Am J Med Genet 20:107–114

    Article  CAS  PubMed  Google Scholar 

  • Biegstraaten M, van Schaik IN, Wieling W, Wijburg FA, Hollak CE (2010) Autonomic neuropathy in Fabry disease: a prospective study using the autonomic symptom profile and cardiovascular autonomic function tests. BMC Neurol 10:38. doi:10.1186/1471-2377-10-38

    Article  PubMed  PubMed Central  Google Scholar 

  • Chandra A, Copen CE (2013) Infertility and impaired fecundity in the United States, 1981-2010: data from the National Survey of Family Growth. Natl Health Stat Rep 67:1–19

    Google Scholar 

  • Chandra A, Copen CE, Stephen EH (2014) Infertility service use in the United States: data from the National Survey of Family Growth, 1982-2010. Natl Health Stat Rep 73:1982–2010

    Google Scholar 

  • Cohen J (1988) Statistical power analysis for the behavior science. Hillsdale, Lawrence Erlbaum Association

    Google Scholar 

  • Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245. doi:10.1093/humupd/dmp048. Epub 2009 Nov 24

    Article  PubMed  Google Scholar 

  • de Groot WP (1964) Angiokeratoma corporis diffusum Fabry (thesaurismosis hereditaria Ruiter-Pompen-Wyers). Dermafologica 128:321

    Article  Google Scholar 

  • Desnick RJ, Ioannou YA et al (2001) Alpha-galactosidase A 364 deficiency: Fabry disease. In: CRBA S, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw Hill, New York, pp 3733–3774

    Google Scholar 

  • Dye JL (2010) Fertility of American women: 2008. Current Population Reports, P20–563. www.census.gov/prod/2010pubs/p20-563.pdf. Accessed 17 Jan 2017

  • Eng CM, Germain DP et al (2006) Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med 8(9):539–548

    Article  PubMed  Google Scholar 

  • Foda MM, Mahmood K, Rasuli P, Dunlap H, Kiruluta G, Schillinger JF (1996) High-flow priapism associated with Fabry’s disease in a child: a case report and review of the literature. Urology 48(6):949–952

    Article  CAS  PubMed  Google Scholar 

  • Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, Lemay R, Linthorst GE, Packman S, Scott CR, Waldek S, Warnock DG, Weinreb NJ, Wilcox WR (2015) Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet 52(5):353–358. doi:10.1136/jmedgenet-2014-102797. Epub 2015 Mar 20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Guin GH, Burns WA, Saini N, Jones WP (1976) Diffuse angiokeratoma (Fabry’s disease). Mil Med 141:259–263

    CAS  PubMed  Google Scholar 

  • Hauser AC, Gessl A, Harm F, Wiesholzer M, Kleinert J, Wallner M, Voigtländer T, Bieglmayer C, Sunder-Plassmann G (2005) Hormonal profile and fertility in patients with Anderson-Fabry disease. Int J Clin Pract 59(9):1025–1028

    Article  CAS  PubMed  Google Scholar 

  • Hershberger PE, Gallo AM, Kavanaugh K, Olshansky E, Schwartz A, Tur-Kaspa I (2012) The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: initial findings from a grounded theory study. Soc Sci Med 74(10):1536–1543

    Article  PubMed  PubMed Central  Google Scholar 

  • Hopkin RJ, Bissler J, Banikazemi M et al (2008) Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry. Pediatr Res 64:550–555

    Article  PubMed  Google Scholar 

  • Hopkin RJ, Jefferies JL, Laney DA, Lawson VH, Mauer M, Taylor MR, Wilcox WR, Fabry Pediatric Expert Panel (2015) The management and treatment of children with Fabry disease: a United States-based perspective. Mol Genet Metab 117:104–113

    Article  PubMed  Google Scholar 

  • Hopkins PV, Campbell C, Klug T, Rogers S, Raburn-Miller J, Kiesling J (2015) Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri. J Pediatr 166(1):172–177. doi:10.1016/j.jpeds.2014.09.023. Epub 2014 Oct 18

    Article  PubMed  Google Scholar 

  • Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC et al (2009) Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later onset GLA mutation c.936+919G4A (IVS4+919G4A). Hum Mutat 30:1397–1405

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Inoue T, Hattori K, Ihara K, Ishii A, Nakamura K, Hirose S (2013) Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J Hum Genet 58:548–552. doi:10.1038/jhg.2013.48

    Article  CAS  PubMed  Google Scholar 

  • Jones RK, Jerman J (2014) Abortion incidence and service availability in the United States, 2011. Perspect Sex Reprod Health 46(1):3–14

    Article  PubMed  Google Scholar 

  • Jones RK, Finer LB, Singh S (2010) Characteristics of U.S. abortion patients, 2008. Guttmacher Institute, New York

    Google Scholar 

  • Jørgensen N, Andersen AG, Eustache F et al (2001) Regional differences in semen quality in Europe. Hum Reprod 16:1012e19

    Article  Google Scholar 

  • Jørgensen N, Joensen UN, Jensen TK, Jensen MB, Almstrup K, Olesen IA, Juul A, Andersson AM, Carlsen E, Petersen JH et al (2012) Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2:1–14

    Article  Google Scholar 

  • Kessler LM, Craig BM, Plosker SM, Reed DR, Quinn GP (2013) Infertility evaluation and treatment among women in the United States. Fertil Steril 100(4):1025–1031

    Article  PubMed  Google Scholar 

  • Krausz C (2011) Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25(2):271–285

    Article  PubMed  Google Scholar 

  • Kreider RM, Lofquist DM (2014) Adopted children and stepchildren: 2010. Current Population Reports, P20-572, US Census Bureau, Washington, DC

    Google Scholar 

  • Labarthe F, de Bodman C, Maruani A, Szwarc C, Froissart R, Lorette G, Lardy H (2010) Priapism: a severe paediatric complication of Fabry disease. Rev Med Interne 31(Suppl 2):S217–S219. doi:10.1016/S0248-8663(10)70015-1. French

    Article  PubMed  Google Scholar 

  • Lacombe D, Germain DP, Papaxanthos-Roche A (2010) Azoospermia as a new feature of Fabry disease. Rev Med Interne 31(Suppl 2):S214–S216. doi:10.1016/S0248-8663(10)70014-X. French

    Article  PubMed  Google Scholar 

  • Laney DA, Gruskin DJ, Metha A (2008) Reproductive fitness in individuals affected by Fabry disease. Mol Genet Metab 93(2):28

    Article  Google Scholar 

  • Laney DA, Gruskin DJ, Fernhoff PM, Cubells JF, Ousley OY, Hipp H, Mehta AJ (2010) Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 33(Suppl 3):S73–S81. doi:10.1007/s10545-009-9025-6. Epub 2010 Jan 20

    Article  PubMed  Google Scholar 

  • Laney DA, Bennett RL, Clarke V, Fox A, Hopkin RJ, Johnson J, O'Rourke E, Sims K, Walter G (2013) Fabry disease practice guidelines: recommendations of the National Society of Genetic Counselors. J Genet Couns 22(5):555–564. doi:10.1007/s10897-013-9613-3. Epub 2013 Jul 17

    Article  PubMed  Google Scholar 

  • Laney DA, Peck DS, Atherton AM, Manwaring LP, Christensen KM, Shankar SP, Grange DK, Wilcox WR, Hopkin RJ (2015) Fabry disease in infancy and early childhood: a systematic literature review. Genet Med 17(5):323–330. doi:10.1038/gim.2014.120. Epub 2014 Sep 18

    Article  PubMed  Google Scholar 

  • Lin HY, Chong KW, Hsu JH et al (2009) High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet 2:450–456

    Article  PubMed  Google Scholar 

  • Martinez G, Daniels K, Chandra A (2012) Division of vital statistics, fertility of men and women aged 15–44 years in the United States: National Survey of Family Growth, 2006–2010. Natl Health Stat Rep 51:1–28

    Google Scholar 

  • Martinez GM, Chandra A, Abma JC, Jones J, Mosher WD (2006) Fertility, contraception, and fatherhood: data on men and women from cycle 6 (2002) of the 2002 national survey of family growth. Vital Health Stat 23(26):1–142

    Google Scholar 

  • Mechtler TP, Stary S, Metz TF, De Jesus VR et al (2012) Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 379:335–341

    Article  PubMed  Google Scholar 

  • Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249–254

    Article  CAS  PubMed  Google Scholar 

  • Nistal M, Paniagua R, Picazo ML (1983) Testicular and epididymal involvement in Fabry’s disease. J Pathol 141:113–124

    Article  CAS  PubMed  Google Scholar 

  • Papaxanthos-Roche A, Deminière C, Bauduer F, Hocké C, Mayer G, Lacombe D (2007) Azoospermia as a new feature of Fabry disease. Fertil Steril 88(1):212.e15–212.e18. Epub 2007 Jan 29

    Article  Google Scholar 

  • Read C (2002) Reproductive decisions of parents of children with metabolic disorders. Clin Genet 61:268–276

    Article  CAS  PubMed  Google Scholar 

  • Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, Schlegel PN, Howards SS, Nehra A, Damewood MD, Overstreet JW, Sadovsky R (2002) Best practice policies for male infertility. Fertil Steril 77(5):873–882

    Article  PubMed  Google Scholar 

  • Smid BE, van der Tol L, Biegstraaten M, Linthorst GE, Hollak CE, Poorthuis BJ (2015) Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet 52(4):262–268. doi:10.1136/jmedgenet-2014-102872. Epub 2015 Jan 16

    Article  CAS  PubMed  Google Scholar 

  • Spada M, Pagliardini S, Yasuda M et al (2006) High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 79:31–40

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spence MW, Clarke JT, D’Entremont DM, Sapp GA, Smith ER, Goldbloom AL, Davar G (1978) Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia. J Med Genet 15(6):428–434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Török L, Szekeres L, Reszler M (1980) Angiokeratoma corporis diffusum in 2 brother. Hautarzt 31(7):376–380. German

    PubMed  Google Scholar 

  • Veronik F, Benko D, Vujkovac B, Linthorst GE (2004) Remarkable variability in renal disease in a large Slovenian family with Fabry disease. Eur J Hum Genet 12(8):678–681

    Article  Google Scholar 

  • Wagner M, Krämer J, Blohm E, Vergho D, Weidemann F, Breunig F, Wanner C (2014) Kidney function as an underestimated factor for reduced health related quality of life in patients with Fabry disease. BMC Nephrol 15:188. doi:10.1186/1471-2369-15-188

    Article  PubMed  PubMed Central  Google Scholar 

  • Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P (2009) Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med 11(11):790–796

    Article  PubMed  Google Scholar 

  • Wang RY, Lelis A et al (2007) Heterozygous Fabry women are not 400 just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9(1):34–45

    Article  CAS  PubMed  Google Scholar 

  • Willott GM (1982) Frequency of azoospermia. Forensic Sci Int 20:9

    Article  CAS  PubMed  Google Scholar 

  • The World Bank (2015) Fertility rate, total (births per woman), United States, 2011–2015. http://data.worldbank.org/indicator/SP.DYN.TFRT.IN. Accessed 17 Dec 2015

  • Zarate YA, Hopkin RJ (2008) Fabry’s disease. Lancet 372:1427–1435

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Our thanks to Genzyme, a Sanofi company, for support of this project. Additional thanks to the individuals who took the time to complete our survey and candidly provide their thoughts on a sensitive issue. We also thank all the collaborating institutions who helped spread the word of this survey to their patients. Our acknowledgment and gratitude also go to the National Fabry Disease Foundation and Fabry Support and Information Group for allowing us to distribute information about our study to their members.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dawn A. Laney .

Editor information

Editors and Affiliations

Additional information

Communicated by: Alberto B. Burlina, MD

Appendices

Summary

Males and females with Fabry disease do not exhibit reduced reproductive fitness; on average they have more biological children than the general population in the United States.

Compliance with Ethics Guidelines

Allison Foley, Myrl Holida, Scott Gillespie, Eric Hall, Morgan Simmons, Alexandrea Wadley, and Virginia Clark declare they have no conflicts of interest.

Dawn Laney consults for Genzyme and Shire, and is a study coordinator in clinical trials sponsored by Genzyme, Amicus, and Protalix. She has also received research funding from Alexion, Amicus, Genzyme, Pfizer, Retrophin, Shire, and Synageva. Grant funding to conduct this investigator initiated studies was provided through an educational grant from Genzyme, A Sanofi company. These activities are monitored and are in compliance with the conflict of interest policies at Emory University School of Medicine.

Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentations (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study. This chapter does not contain any studies with animal subjects performed by any of the authors.

Contributions

Planning of this study, oversight, data collection, analysis, and reporting of work were coordinated by Dawn Laney. Statistical analysis and manuscript authorship by Scott Gillespie and Eric Hall. Subject recruitment, data collection, and manuscript creation review by Alexandrea Wadley. Data analysis and manuscript review and editing by Morgan Simmons and Allison Foley. Subject recruitment and manuscript authorship/review by Myrl Holida and Virginia Clarke.

Appendix 1: FIT Survey Sample Questions. Questions Were Presented to Be Answered as Self-Response Multiple Choice, Yes or No, and Free Response Answers

FIT survey

Sample question asked

Males

Part 2. General Questions

“Do you have any biological children?”

Yes: _____ Number of boys ____ Number of girls _____

No, but I have adopted children

No, I do not have any children biological or adopted

“Have you ever gotten one of your partners pregnant?”

“Have you ever had difficulties getting your partner pregnant?”

   Yes (please describe) __________________

   No

   I have never tried to make my partner pregnant

“Have you ever experienced issues with infertility?”

“Have you ever been used assisted reproductive technology?”

   Yes, my partner took hormones to increase ovulation

   Yes, we used a donor egg

   Yes, we used a donor sperm

   Yes we used in vitro fertilization

   Yes, we used in vitro fertilization and preimplantation genetic diagnosis

   No, we have never used assisted reproductive technology

Part 3. Medical History

“Have you ever experienced any of the following health issues?”

Hypertension/High Blood pressure, beginning at age ___

Burning pain in your hands/feet, beginning at age ___

Fabry pain crises, beginning at age ___

Depression, beginning at age ___

Anxiety, beginning at age ___

Panic Attacks, beginning at age ___

Kidney failure, beginning at age ___

Liver disease, beginning at age ___

Erectile dysfunction, beginning at age ___

Low sperm count, beginning at age ____

No, none of the above.

“Do you take any medications for high blood pressure?”

   Yes, ______________ (medication) beginning at age ___________

“Have you ever been treated for cancer or a tumor?”

“Have you ever worked in a job that included frequent exposure to industrial chemical, pesticides, lead, heavy metals, or radiation/Xrays?”

Part 4. Family History

“Did you know that you had Fabry disease before you considered having children?”

“If you did know that you had Fabry disease prior to having children, did having Fabry disease affect your decision to have children?”

“Anything else about your reproductive history or having babies while living with Fabry disease that you think we should know?”

Females

Part 2. Medical History

“Have you ever experienced any of the following health issues?”

Burning pain in your hands/feet, beginning at age ____

Depression, beginning at age ____

Kidney failure, beginning at age ____

Polycystic ovaries, beginning at age ___

Abnormal uterine shape

Endometriosis, beginning at age ___

An STD such as herpes, which one? ___

Other chronic health issue(s) (other than Fabry disease) not mentioned above

Part 3. Reproductive History

“Have you ever been pregnant”

If yes, number of times and how old were you during the first trimester of each?

If no, have you ever tried to become pregnant?

“At what age did you begin having your periods?”

“Have you ever had difficulties getting pregnant?”

   Yes (please describe _________)

   No

   I have never tried to become pregnant.

“Have you ever had any concerns about your ability to have children?”

“Have you ever experienced any issues with infertility?”

“Have you ever been evaluated for infertility concerns?”

“Have you ever been used assisted reproductive technology?”

   Yes, I took hormones to increase ovulation

   Yes, I used a donor egg

   Yes, I used a donor sperm

   Yes, I used in vitro fertilization

   Yes, I used in vitro fertilization and preimplantation genetic diagnosis

   No, I have never used assisted reproductive technology

“Have you ever experienced menopause?”

Part 4. Pregnancy History

“How many times have you been pregnant?”

“Have you ever had a miscarriage?”

“Have you ever had an elective termination of a pregnancy?”

“Have you ever had a termination of a pregnancy for medication reasons?”

“How many children have you given birth to ___boys ___girls?”

“Were any of your children stillborn or died soon after birth?”

“Do you have any adopted children?”

Part 5. Family history

“Did you know that you had Fabry disease before having children?”

If you did know that you had Fabry disease prior to having children, did having Fabry disease affect your decision to have children?

Appendix 2: Reproductive Decision-Making and Fabry Disease (Selection of Free Response Answers)

Impact reported on the reproductive decision-making process of the knowledge that they had Fabry disease

Patient quotes

No negative impact

“No, it <having Fabry disease> didn’t matter … My wife and I discussed Fabrys, and decided we wanted at least 2 children.”

“No, not at all. My dad always told me he had enjoyed his life and was glad he was born and hated when his dad told him if he knew his boys would have Fabrys he wouldn’t have had them.”

“No, but it has changed that decision for some of my family members. I figure my life, even though not easy, is worth it. So my kids if they got it would feel the same way. Some of my family have a harder time with that feeling.”

Mixed impact

“Yes, from age 18 I was certain I did not want children because I did not want the disease to continue. I was the youngest person in my family that had Fabry and the disease would end with me. My brother had two kids, but male, so I would be the last of it. But then I got married and I changed my mind and wanted children.”

Negative impact

“The treat<ment> is great for many reasons, but the pain from neuropathy is not controlled enough for me to be comfortable in having a child who could possibly go through the type of pain I did growing up.”

“YES … I had a tubal ligation at age 24”

“Once I knew I had Fabry it was sort of the final straw in deciding if we should have kids or not. I felt selfish possibly bringing a child into the world with Fabry. I know this doesn’t take into consideration all of the other facets of a child, and that if my mom had chosen that, then I wouldn’t be here. But for me I would feel so guilty watching a child suffer the symptoms of Fabry, knowing I chose that for them, in sense.”

Rights and permissions

Reprints and permissions

Copyright information

© 2017 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Laney, D.A. et al. (2017). The Impact of Fabry Disease on Reproductive Fitness. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 37. JIMD Reports, vol 37. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2017_17

Download citation

  • DOI: https://doi.org/10.1007/8904_2017_17

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-56358-8

  • Online ISBN: 978-3-662-56359-5

  • eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)

Publish with us

Policies and ethics